Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial

We studied the activity of combined oxaliplatin and fluorouracil-leucovorin in 16 consecutive patients with advanced biliary tract adenocarcinomas. The disease control rate (responses and stable disease) was 56% (95% confidence interval, 29–84%) and the median overall survival time was 9.5 months (r...

Descripción completa

Detalles Bibliográficos
Autores principales: Nehls, O, Klump, B, Arkenau, H T, Hass, H G, Greschniok, A, Gregor, M, Porschen, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364257/
https://www.ncbi.nlm.nih.gov/pubmed/12232749
http://dx.doi.org/10.1038/sj.bjc.6600543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364257/
https://www.ncbi.nlm.nih.gov/pubmed/12232749
http://dx.doi.org/10.1038/sj.bjc.6600543

Ejemplares similares